Cannabidiol and cannabigerol effect on cognitive deficit induced by intracerebroventricular administration of amyloid beta 42 in experimental Alzheimer’s disease model
Indian Journal of Experimental Biology · 62(12), 937–948
Open source ↗ Corporate structure in preparation
Science · Research · Laboratory · Industrial R&D
Connecting new technologies with Türkiye’s research and production ecosystem.
We assess scientific, laboratory, healthcare and industrial R&D technologies and develop appropriate pathways for universities, laboratories, institutions and production facilities in Türkiye.
What We Do
From scientific evidence to a credible pathway for Türkiye.
We combine scientific assessment, local market analysis and structured partnership development within one clear framework of responsibility.
01
Scientific and Technical Assessment
Scientific basis, technical fit, maturity and intended use.
+02Türkiye Market Analysis
Needs, sectors, stakeholders, competition and realistic entry routes.
+03Partnership Development
Reliable pathways to universities, laboratories, healthcare and industry institutions.
+Initial scope: Importation, licence ownership, inventory, logistics, clinical services and sales guarantees remain outside scope unless covered by a separate agreement and verified operational capacity.
Technology Areas
Focused on research and production needs, not isolated specialties.
We address the needs of institutions from universities to production facilities across a broad technology map, while limiting claims of expertise and representation according to the available evidence.
Need-led technology area
Explore the technology areas ↗01
Research and Life Sciences
Biotechnology, pharmacology, cellular systems, biomarkers and applied research.
Need-led technology area02
Laboratory and Analytical Systems
Spectroscopy, chromatography, Raman, ELISA, microscopy and research infrastructure.
Need-led technology area03
Pharmaceutical and Medical Technologies
Drug development, diagnostic systems, medical devices and health technologies.
Need-led technology area04
Industrial R&D and Quality
Production laboratories, quality control, process development and validation needs.
Need-led technology area05
Materials and Process Analytics
Materials characterisation, sensors, automation and process-analysis technologies.
Field under active review06
Emerging Technologies
AI-assisted analysis, advanced data systems and new fields as their evidence base develops.
Who We Work With
Wherever research is conducted, measurement is needed and production is advancing.
Universities, research centres, public and private laboratories, healthcare institutions, industrial R&D units and production facilities.
01
Introduce your technology
Share a non-confidential overview, current evidence and your objective in Türkiye.
02
Assess the fit
Review the scientific basis, evidence quality, need and suitability of the proposed role.
03
Map the Türkiye pathway
Assess stakeholders, constraints, competition and partnership options.
04
Develop the engagement process
Prioritise suitable institutions and coordinate a structured route forward.
An initial discussion does not constitute approval, representation, exclusivity, distribution or a guarantee of market outcomes.
Scientific Leadership
Scientific judgement. Market experience. Personal responsibility.
Arda Can Aydın is a biologist and pharmacology researcher with experience in experimental neuroscience, Alzheimer’s disease models and the translation of scientific findings into practice.
He combines this scientific background with field and business-development experience in pharmaceuticals, biotechnology-related solutions, medical technologies and laboratory systems in Türkiye.
Publication-ready evidence02
Verified peer-reviewed publications
BSc Biology · MSc Pharmacology · Alzheimer’s disease model research
Scientific Evidence
A research foundation with an expanding view of technology.
Only verified publications are presented; manuscripts under review are not represented as published work.
Alzheimer’s Disease and Dementia
Journal of Literature Pharmacy Sciences · 9(2), 125–136
Open source ↗Evaluate the right pathway for Türkiye
Are you exploring a credible partnership pathway for your technology?
Introduce your organisation, technology, current evidence stage and objective in Türkiye. We will assess whether there is a meaningful basis for an initial discussion.
Introduce Your Technology ↗